Nilotinib in Huntington’s Disease
Condition(s):Huntington DiseaseLast Updated:February 20, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Huntington DiseaseLast Updated:February 20, 2020Unknown status
Condition(s):Raynaud PhenomenonLast Updated:March 5, 2024Recruiting
Condition(s):Chronic Pain; Chronic Pelvic Pain Syndrome; Myofascial Pain Syndrome; Myofascial Trigger Point Pain; Pelvic Floor DisordersLast Updated:April 11, 2023Recruiting
Condition(s):Mild Cognitive Impairment; Memory ImpairmentLast Updated:April 6, 2023Recruiting
Condition(s):Alzheimer Disease; Parkinson DiseaseLast Updated:February 28, 2023Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:April 23, 2021Unknown status
Condition(s):Mild Cognitive Impairment; Alzheimer DiseaseLast Updated:September 25, 2023Completed
Condition(s):NeurotoxicityLast Updated:November 10, 2021Terminated
Condition(s):Amyotrophic Lateral SclerosisLast Updated:August 11, 2022Completed
Condition(s):Anesthesia; Neuron DegenerationLast Updated:March 17, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.